Trojanowski Amy 4
4 · Chemours Co · Filed Mar 5, 2019
Insider Transaction Report
Form 4
Trojanowski Amy
VP and Controller
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2019-03-01−9,436→ 0 totalExercise: $11.87Exp: 2020-02-05→ Common Stock (9,436 underlying) - Award
Stock Option (Right to Buy)
2019-03-05+9,756→ 9,756 totalExercise: $38.02Exp: 2029-03-01→ Common Stock (9,756 underlying) - Exercise/Conversion
Common Stock
2019-03-01$11.87/sh+9,436$111,999→ 54,367 total - Sale
Common Stock
2019-03-01$38.63/sh−9,436$364,505→ 44,940 total - Sale
Common Stock
2019-03-01$38.63/sh−4,100$158,380→ 44,940 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-03-01−4,100→ 9,049 totalExercise: $15.49Exp: 2021-02-04→ Common Stock (4,100 underlying) - Exercise/Conversion
Common Stock
2019-03-01$15.49/sh+4,100$63,497→ 49,040 total
Footnotes (3)
- [F1]Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $38.10 to $39.00.
- [F2]The options are fully exercisable.
- [F3]The options vest in three equal annual installments beginning on March 1, 2020.